Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pascal Defaye

Showing results (91-100 of 264) with videos related to

Pageof 27
Sort By:
Journal of the American College of Cardiology|September 10, 2016
Electrical Storms in Patients With Implantable Cardioverter-Defibrillators for Primary PreventionWilliam Escande, Eloi Marijon, Pascal Defaye, et al.
Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference|January 18, 2020
A novel bimodal stethoscope for gastric collection of heart sounds: preliminary resultsCindy Dopierala, Francois Boucher, Mohamed-Ridha Frikha, et al.
International Journal of Cardiology|December 15, 2021
Implantable cardiac devices in sleep apnoea diagnosis: A systematic review and meta-analysisRaoua Ben Messaoud, Charles Khouri, Jean Louis Pépin, et al.
Archives of Cardiovascular Diseases|April 27, 2020
Subcutaneous implantable cardioverter defibrillator indication in prevention of sudden cardiac death in difficult clinical situations: A French expert position paperVincent Probst, Serge Boveda, Nicolas Sadoul, et al.
Journal of Cardiac Failure|August 28, 2010
Addition of a second LV pacing site in CRT nonresponders rationale and design of the multicenter randomized V(3) trialPierre Bordachar, Christine Alonso, Frederic Anselme, et al.
Pacing and Clinical Electrophysiology : PACE|December 16, 2006
Improvement of quality of life by means of antitachy pacing: from PainFREE to the ADVANCE-D TrialMaurizio Lunati, Pascal Defaye, Johann Mermi, et al.
European Heart Journal|September 3, 2014
Long-term clinical effects of ventricular pacing reduction with a changeover mode to minimize ventricular pacing in a general pacemaker populationMartin Stockburger, Serge Boveda, Javier Moreno, et al.
Journal of the American College of Cardiology|September 2, 2017
Outcomes in Guideline-Based Versus Off-Guideline Primary Prevention Implantable Cardioverter-Defibrillator RecipientsWilliam Escande, Serge Boveda, Pascal Defaye, et al.
Archives of Cardiovascular Diseases|May 2, 2020
Use of drugs with potential cardiac effect in the setting of SARS-CoV-2 infectionFrederic Sacher, Laurent Fauchier, Serge Boveda, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|January 25, 2018
Primary safety results from the LEADLESS Observational StudyJohannes Sperzel, Pascal Defaye, Peter-Paul Delnoy, et al.
Pageof 27

Showing results (91-100 of 264) with videos related to

Sort By:
Pageof 27
Journal of the American College of Cardiology|September 10, 2016
Electrical Storms in Patients With Implantable Cardioverter-Defibrillators for Primary PreventionWilliam Escande, Eloi Marijon, Pascal Defaye, et al.
Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference|January 18, 2020
A novel bimodal stethoscope for gastric collection of heart sounds: preliminary resultsCindy Dopierala, Francois Boucher, Mohamed-Ridha Frikha, et al.
International Journal of Cardiology|December 15, 2021
Implantable cardiac devices in sleep apnoea diagnosis: A systematic review and meta-analysisRaoua Ben Messaoud, Charles Khouri, Jean Louis Pépin, et al.
Archives of Cardiovascular Diseases|April 27, 2020
Subcutaneous implantable cardioverter defibrillator indication in prevention of sudden cardiac death in difficult clinical situations: A French expert position paperVincent Probst, Serge Boveda, Nicolas Sadoul, et al.
Journal of Cardiac Failure|August 28, 2010
Addition of a second LV pacing site in CRT nonresponders rationale and design of the multicenter randomized V(3) trialPierre Bordachar, Christine Alonso, Frederic Anselme, et al.
Pacing and Clinical Electrophysiology : PACE|December 16, 2006
Improvement of quality of life by means of antitachy pacing: from PainFREE to the ADVANCE-D TrialMaurizio Lunati, Pascal Defaye, Johann Mermi, et al.
European Heart Journal|September 3, 2014
Long-term clinical effects of ventricular pacing reduction with a changeover mode to minimize ventricular pacing in a general pacemaker populationMartin Stockburger, Serge Boveda, Javier Moreno, et al.
Journal of the American College of Cardiology|September 2, 2017
Outcomes in Guideline-Based Versus Off-Guideline Primary Prevention Implantable Cardioverter-Defibrillator RecipientsWilliam Escande, Serge Boveda, Pascal Defaye, et al.
Archives of Cardiovascular Diseases|May 2, 2020
Use of drugs with potential cardiac effect in the setting of SARS-CoV-2 infectionFrederic Sacher, Laurent Fauchier, Serge Boveda, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|January 25, 2018
Primary safety results from the LEADLESS Observational StudyJohannes Sperzel, Pascal Defaye, Peter-Paul Delnoy, et al.
Pageof 27